DK0634934T3 - Anvendelse af diætmæssige valleproteiner til behandling af HIV-seropositive individer - Google Patents
Anvendelse af diætmæssige valleproteiner til behandling af HIV-seropositive individerInfo
- Publication number
- DK0634934T3 DK0634934T3 DK93907682T DK93907682T DK0634934T3 DK 0634934 T3 DK0634934 T3 DK 0634934T3 DK 93907682 T DK93907682 T DK 93907682T DK 93907682 T DK93907682 T DK 93907682T DK 0634934 T3 DK0634934 T3 DK 0634934T3
- Authority
- DK
- Denmark
- Prior art keywords
- seropositive individuals
- whey proteins
- treat hiv
- hiv seropositive
- dietary whey
- Prior art date
Links
- 108010046377 Whey Proteins Proteins 0.000 title abstract 2
- 235000021119 whey protein Nutrition 0.000 title abstract 2
- 235000005911 diet Nutrition 0.000 title 1
- 230000000378 dietary effect Effects 0.000 title 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 abstract 4
- 229960003180 glutathione Drugs 0.000 abstract 2
- 210000002443 helper t lymphocyte Anatomy 0.000 abstract 2
- 108010024636 Glutathione Proteins 0.000 abstract 1
- 102000007544 Whey Proteins Human genes 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 230000037396 body weight Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 239000012141 concentrate Substances 0.000 abstract 1
- 210000005087 mononuclear cell Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Polymers & Plastics (AREA)
- Marine Sciences & Fisheries (AREA)
- Nutrition Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/866,756 US5456924A (en) | 1988-12-23 | 1992-04-10 | Method of treatment of HIV-seropositive individuals with dietary whey proteins |
| PCT/CA1993/000107 WO1993020831A1 (en) | 1992-04-10 | 1993-03-22 | Method of treatment of hiv-seropositive individuals with dietary whey proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0634934T3 true DK0634934T3 (da) | 2000-06-13 |
Family
ID=25348339
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK93907682T DK0634934T3 (da) | 1992-04-10 | 1993-03-22 | Anvendelse af diætmæssige valleproteiner til behandling af HIV-seropositive individer |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5456924A (zh) |
| EP (1) | EP0634934B1 (zh) |
| JP (1) | JP2738592B2 (zh) |
| KR (1) | KR100297959B1 (zh) |
| CN (1) | CN1070371C (zh) |
| AT (1) | ATE187335T1 (zh) |
| AU (1) | AU687731B2 (zh) |
| CA (1) | CA2090186C (zh) |
| CZ (1) | CZ283386B6 (zh) |
| DE (1) | DE69327236T2 (zh) |
| DK (1) | DK0634934T3 (zh) |
| ES (1) | ES2143503T3 (zh) |
| IL (1) | IL105339A (zh) |
| MX (1) | MX9302057A (zh) |
| NO (1) | NO317795B1 (zh) |
| NZ (1) | NZ251271A (zh) |
| TW (1) | TW384223B (zh) |
| WO (1) | WO1993020831A1 (zh) |
| ZA (1) | ZA932526B (zh) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5531989A (en) | 1994-10-28 | 1996-07-02 | Metagenics, Inc. | Immunoglobulin and fiber-containing composition for human gastrointestinal health |
| US6241983B1 (en) | 1994-10-28 | 2001-06-05 | Metagenics, Inc. | Bacteria-and fiber-containing composition for human gastrointestinal health |
| US5985275A (en) * | 1995-04-12 | 1999-11-16 | New York Blood Center | β-Lactoglobulin modified with aromatic anhydride compound for preventing HIV infection |
| CA2165937A1 (en) * | 1995-05-09 | 1996-11-10 | Immunotec Research Corporation Ltd. | Process for producing an undenatured whey protein concentrate |
| WO1997032483A1 (en) * | 1996-03-06 | 1997-09-12 | I. Belloch Corporation | Method for treating liquid materials |
| AU1707197A (en) * | 1996-03-20 | 1997-10-10 | New York Blood Center, Inc., The | Methods of treating herpes or chlamydia |
| US5952009A (en) * | 1996-03-20 | 1999-09-14 | New York Blood Center | Methods for preventing the transmission of or treating patients infected with herpesvirus |
| US6262019B1 (en) | 1998-04-30 | 2001-07-17 | Vit-Immune, L. C. | Method of treatment of glutathione deficient mammals |
| US6667063B2 (en) | 1998-06-10 | 2003-12-23 | Albert Crum | Nutritional or therapeutic supplement and method |
| ATE322275T1 (de) * | 1998-06-10 | 2006-04-15 | Albert B Crum | Vorbeugender und therapeutischer nahrungsmittelzusatz zur schaffung/erhaltung einer die gesundheit schützenden darmmikroflora und zur stärkung des immunsystems |
| US6203805B1 (en) | 1998-11-10 | 2001-03-20 | Color Access, Inc. | Topical compositions containing whey proteins |
| US6864242B2 (en) | 2001-03-05 | 2005-03-08 | Stephen P. Ernest | Enteral formulation |
| US6503506B1 (en) * | 2001-08-10 | 2003-01-07 | Millenium Biotechnologies, Inc. | Nutrient therapy for immuno-compromised patients |
| ES2451618T3 (es) | 2001-12-20 | 2014-03-28 | Biolactis Inc. | Matriz de proteína maleable y usos de estas |
| FR2840318B1 (fr) * | 2002-05-29 | 2004-12-03 | Quoc Kiet Pham | Nouveaux sulfolipides antiretroviraux extraits de spirulines, leur procede d'obtention, les compositions les contenant et leur utilisation comme inhibiteurs de la transcriptase inverse des virus vih |
| FR2889067B1 (fr) * | 2005-07-29 | 2011-11-11 | Cie Laitiere Europeenne | "utilisation d'une fraction proteique laitiere pour preparer une composition amincissante et/ou ameliorant la composition corporelle" |
| DE102006052504A1 (de) | 2006-11-06 | 2008-05-08 | Temper, Rupert | Verfahren zum Herstellen eines Mittels gegen eine Infektionskrankheit |
| US20080119386A1 (en) * | 2006-11-22 | 2008-05-22 | Carl Germano | Nutritional formula for athletes' recovery |
| AP2009004963A0 (en) * | 2007-02-06 | 2009-10-31 | Cymcorp Internat Inc | Novel non-toxic composition and method of using such for treating a degenerative or an immune systemrelated disease |
| US20100069288A1 (en) * | 2008-09-12 | 2010-03-18 | Wulf Droge | Use of cysteine-rich whey derived protein in patients receiving chemotherapy or radiotherapy to improve patient survival |
| JP2013079216A (ja) * | 2011-10-04 | 2013-05-02 | Snow Brand Milk Products Co Ltd | 感覚改善剤 |
| JP6234777B2 (ja) * | 2013-10-31 | 2017-11-22 | 株式会社日立製作所 | 光多値送信器および光トランスポンダ |
| DE102014001037A1 (de) * | 2014-01-25 | 2015-07-30 | Gea Tds Gmbh | Verfahren und Vorrichtung zur Reduzierung des Wachstums thermophiler Keime in Magermilch |
| US20190262401A1 (en) | 2016-09-23 | 2019-08-29 | Immunotec Inc. | Compositions for restoring gene expression in neuropsychiatric or neurodegenerative disorders |
| CA2970699A1 (en) | 2017-06-14 | 2018-12-14 | Elizabeth E. Ignowski | Compositions for increasing resilience to traumatic brain injury |
| WO2019027974A1 (en) | 2017-07-31 | 2019-02-07 | Immunotec Inc. | COMPOSITIONS AND METHODS FOR TREATING AUTISM SPECTRUM DISORDER |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA858533A (en) * | 1970-12-15 | Lahav Eitan | Polypeptidic antibiotic substances derived from casein by fermentation | |
| FR2565985B1 (fr) * | 1984-06-19 | 1987-09-25 | Rhone Poulenc Sante | Nouvelles substances biologiquement actives obtenues a partir de la caseine bovine, leur procede de preparation et les compositions qui les contiennent |
| US4880626A (en) * | 1985-01-18 | 1989-11-14 | Mcmichael John | Immunotherapeutic methods and compositions for the treatment of diseases of viral origin, including acquired immune deficiency syndrome |
| US4983387A (en) * | 1986-05-19 | 1991-01-08 | Viral Technologies Inc. | HIV related peptides, immunogenic antigens, and use therefor as subunit vaccine for AIDS virus |
| US5030449A (en) * | 1988-07-21 | 1991-07-09 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Synthetic vaccine against AIDS virus |
| EP0338229B1 (de) * | 1988-04-19 | 1993-06-16 | Biotest Pharma Gmbh | Präparat mit Antikörperaktivität und breitem Wirkungsspektrum, daraus bestehende oder diese enthaltende Mittel und deren Verwendung zur Behandlung von bakteriell oder toxin-bedingten Erkrankungen und zur Bekämpfung von Protozoen |
| FI892006A (fi) * | 1988-04-29 | 1989-10-30 | Phil Gold | Lactalbumin saosom tillaeggsaemne i mat. |
| CA1338682C (en) * | 1988-12-23 | 1996-10-29 | Gustavo Bounous | Biologically active undenatured whey protein concentrate as food supplement |
| CA2007258A1 (en) * | 1989-01-11 | 1990-07-11 | Richard L. Jackson | Heparin fraction with anti-hiv activity |
| ATE108335T1 (de) * | 1989-03-03 | 1994-07-15 | Microgenesys Inc | Kit oder zusammensetzung zur vorbeugung oder behandlung von hiv-1 infektionen. |
| EP0432249B1 (en) * | 1989-06-02 | 1996-09-25 | The Johns Hopkins University School Of Medicine | Monoclonal antibodies against leukocyte adhesion receptor beta-chain, methods of producing these antibodies and use therefore |
| CA2022394A1 (en) * | 1989-08-07 | 1991-02-08 | Allen I. Oliff | Peptide inhibitors of human papilloma virus protein binding to retinoblastoma gene proteins |
| ATE366311T1 (de) * | 1989-12-22 | 2007-07-15 | Hoffmann La Roche | Zytotoxischer lymphozyten-reifefaktor 35kd untereinheit und monoklonale antikörper spezifisch dafür |
| US5112373A (en) * | 1991-06-17 | 1992-05-12 | Hung Pham | Apparatus for controlling and eliminating vapor emissions at a manicure work station |
-
1992
- 1992-04-10 US US07/866,756 patent/US5456924A/en not_active Expired - Lifetime
-
1993
- 1993-02-23 CA CA002090186A patent/CA2090186C/en not_active Expired - Lifetime
- 1993-03-22 DE DE69327236T patent/DE69327236T2/de not_active Expired - Lifetime
- 1993-03-22 JP JP5517869A patent/JP2738592B2/ja not_active Expired - Lifetime
- 1993-03-22 ES ES93907682T patent/ES2143503T3/es not_active Expired - Lifetime
- 1993-03-22 DK DK93907682T patent/DK0634934T3/da active
- 1993-03-22 NZ NZ251271A patent/NZ251271A/en unknown
- 1993-03-22 KR KR1019940703473A patent/KR100297959B1/ko not_active IP Right Cessation
- 1993-03-22 EP EP93907682A patent/EP0634934B1/en not_active Expired - Lifetime
- 1993-03-22 WO PCT/CA1993/000107 patent/WO1993020831A1/en active IP Right Grant
- 1993-03-22 AT AT93907682T patent/ATE187335T1/de active
- 1993-03-22 AU AU38812/93A patent/AU687731B2/en not_active Expired
- 1993-03-22 CZ CZ942461A patent/CZ283386B6/cs not_active IP Right Cessation
- 1993-04-07 MX MX9302057A patent/MX9302057A/es unknown
- 1993-04-08 IL IL10533993A patent/IL105339A/en not_active IP Right Cessation
- 1993-04-08 ZA ZA932526A patent/ZA932526B/xx unknown
- 1993-04-09 CN CN93104081A patent/CN1070371C/zh not_active Expired - Lifetime
- 1993-04-09 TW TW082102661A patent/TW384223B/zh not_active IP Right Cessation
-
1994
- 1994-10-07 NO NO19943804A patent/NO317795B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JPH07504677A (ja) | 1995-05-25 |
| CZ283386B6 (cs) | 1998-04-15 |
| CA2090186C (en) | 1999-03-16 |
| ATE187335T1 (de) | 1999-12-15 |
| NZ251271A (en) | 1998-05-27 |
| MX9302057A (es) | 1994-07-29 |
| DE69327236D1 (de) | 2000-01-13 |
| CN1083704A (zh) | 1994-03-16 |
| ZA932526B (en) | 1994-03-09 |
| WO1993020831A1 (en) | 1993-10-28 |
| CZ246194A3 (en) | 1995-04-12 |
| CN1070371C (zh) | 2001-09-05 |
| CA2090186A1 (en) | 1993-10-11 |
| JP2738592B2 (ja) | 1998-04-08 |
| ES2143503T3 (es) | 2000-05-16 |
| AU3881293A (en) | 1993-11-18 |
| IL105339A0 (en) | 1993-08-18 |
| IL105339A (en) | 1998-07-15 |
| EP0634934B1 (en) | 1999-12-08 |
| AU687731B2 (en) | 1998-03-05 |
| US5456924A (en) | 1995-10-10 |
| TW384223B (en) | 2000-03-11 |
| EP0634934A1 (en) | 1995-01-25 |
| NO943804D0 (no) | 1994-10-07 |
| DE69327236T2 (de) | 2000-03-30 |
| KR950700752A (ko) | 1995-02-20 |
| KR100297959B1 (ko) | 2001-10-24 |
| NO943804L (no) | 1994-10-07 |
| NO317795B1 (no) | 2004-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0634934T3 (da) | Anvendelse af diætmæssige valleproteiner til behandling af HIV-seropositive individer | |
| DE69328777D1 (de) | Dekontaminierung von Plättchen mit 8-Methoxypsoralen | |
| DK148889D0 (da) | Fremgangsmaade til foroegelse af extracellulaert adenosin og til stabilisering af mastceller | |
| DE69721006D1 (de) | Verwendung des modifizierten eigenen blutes zur behandlung von autoimmunerkrankungen | |
| MY102472A (en) | Preparation of funtional human urokinase proteins. | |
| NO983372L (no) | Modulering av TH1/TH2 cytokinekspresjon av Ribavirin og Ribavirinanaloger i aktiverte T-lymfocytter | |
| DE69821740D1 (de) | Behandlung von hämoglobin enthaltenden erythrozyten mit stickstoffoxyd | |
| Yamashita et al. | Response of superoxide anion production by guinea pig eosinophils to various soluble stimuli: comparison to neutrophils | |
| SE8505047D0 (sv) | Fettemulsion | |
| Fernandez-Sousa et al. | Variation of superoxide dismutases during the development of the fruit fly Ceratitis capitata L | |
| DK0502313T3 (da) | Fremgangsmåde til sikring af tilstrækkeligt intracellulært glutathion i væv | |
| Alter et al. | Electrophoretic separation of human embryonic globin demonstrates “α-thalassemia” in human leukemia cell line K562 | |
| DE69833225D1 (de) | Verwendung von histamin um die blutkonzentration des histamins zu erhöhen | |
| Borkow et al. | Selective lysis of virus-infected cells by cobra snake cytotoxins: A sendai virus, human erythrocytes, and cytotoxin model | |
| EP1240899A3 (en) | Modulation of Th1/Th2 Cytokine expression by Ribavirin and Ribavirin analogs in actived T-Lymphocytes for treating HCV infections | |
| FI881123A (fi) | Inaktivering av human immunodeficiency virus (hiv) medelst fenol i proteinhaltiga loesningar. | |
| NZ243860A (en) | Increasing glutathione levels in human and animal organs using whey protein concentrate | |
| Peters et al. | Amino Acids and L-Asparaginase Activity in the Plasma of Owl Monkeys (Aotus trivirgatus) | |
| 築山恭子 et al. | Bovine platelet-derived factor showing mitogenic activity on bovine leukemia virus-infected lymphocytes. | |
| MOROZ et al. | The relationship of potassium and sodium content, ATPase activity, and ATP content in the blood of burn victims | |
| FR2622108B1 (fr) | Preparation de concentres de proconvertine (facteur vii), de facteur antihemophilique b (facteur ix) et d'autres proteines plasmatiques, et leur utilisation therapeutique |